The publication addresses the drugs and development nexus from a range of critical viewpoints, highlighting gaps and contradictions, and exploring opportunities for enhanced linkages between drug policy and development programming.

Ana Liffey analyses the country's legal framework and growing body of evidence in favour of decriminalisation, concluding on the urgent need to stop criminalising people who use drugs.

This publication explores how international drug conventions limit state's prioritisation of access to essential medicine.

Csete and Wolfe warn that though a public health approach is gaining pace at the international level, many "treatments" are neither voluntary nor evidence-based.

The Johns Hopkins–Lancet Commission on Drug Policy and Health has sought to examine the emerging scientific evidence on public health issues arising from drug-control policy.

This report documents both the wastefulness of ineffective policies and the missed opportunity of failing to invest in policies and programs that embody good public health practice and human rights norms.

This OSF paper summarises elements of a growing consensus among international bodies on what constitutes good practice in drug prevention programmes. It also assesses some of the challenges of drawing lessons from the existing body of published work on the subject.

Drug policy-makers should benefit from lessons of policies that have succeeded in reducing the harms associated with drug use and repressive law enforcement approaches to drugs.

Despite Thailand's official reclassification of drug users as "patients" deserving care and not "criminals," the Thai government has continued to rely heavily on punitive responses to drug use such as "boot camp"-style compulsory "treatment" centers.